VIVEbiotech participates in a roundtable article in Pharma’s Almanac
25 Jun 2024 //
PRESS RELEASE
iMM Joins the MAGIC Consortium to Advance Research on Muscular Dystrophies
07 Jun 2024 //
PRESS RELEASE
VIVEbiotech receives the “New Company of Gipuzkoa 2024†award from ADEGI
31 May 2024 //
PRESS RELEASE
IBTV interviews Natalia Elizalde during ASGCT´s annual meeting
28 May 2024 //
PRESS RELEASE
VIVEbiotech participates at the SLAS Europe 2024 Conference & Exhibition
24 May 2024 //
PRESS RELEASE
VIVEbiotech Participates In ASGCT Annual Meeting In Baltimore
09 May 2024 //
PRESS RELEASE
VIVEbiotech participates in Cell & Gene Meeting on the Mediterranean
10 Apr 2024 //
PRESS RELEASE
VIVEbiotech is participating in the 19th edition the Advanced Therapies Congress
19 Mar 2024 //
PRESS RELEASE
VIVEbiotech Forecasts Growth In Lentiviral Vectors And CAR-T Therapies
14 Feb 2024 //
PRESS RELEASE
VIVEbiotech Featured In Drug Discovery World Magazine
23 Jan 2024 //
PRESS RELEASE
VIVEbiotech Collaborates On Webinar With Xpress Biologics And Others
23 Jan 2024 //
PRESS RELEASE
Spain`s VIVEbiotech expands lentiviral vector production
07 Jun 2021 //
FIERCEPHARMA
VIVEbiotech to Expand Facilities for Lentiviral-Vector Manufacturing
24 Feb 2021 //
PHARMTECH